sanotize enovid
enovid covid
buy enovid
enovid user guide

5-PACK Enovid SaNOtize Nasal Spray


Regular price $176.00 Sale price$147.00
/
  • In stock, ready to ship
  • Inventory on the way

EXPIRY DATE:  May 2026

SaNOtize NONS is a nitric oxide nasal spray that releases a small dose of nitric oxide and is designed to kill viruses in the upper airways.

SaNOtize nasal spray prevents viruses from incubating and spreading to the lungs by providing a physical and chemical barrier. It doesn’t just block viruses, but actually kills them. 

Use for daily protection: Enovid can be used daily as a proactive measure; Apply 2-3 times daily (2 sprays per nostril during each use) before and after being in high-risk environments.  

How to use after suspected exposure to viruses: Administrate it 5 times a day (2 sprays per nostril during each use) following suspected exposure to viruses.

Results of Phase 3 clinical trial: Enovid was shown to reduce viral load in COVID-19 patients by more than 94% within 24 hours, and by 99% in 48 hours (trial conducted by SaNOtize and Glenmark). Patients in the clinical trial were self-administered a dose of 2 sprays per nostril, six times a day for a seven-day treatment period, along with standard supportive care.

Each sprayer contains 25ml, around 200 doses of spray, or 50 administrations (about a month's supply).

Ingredients: Sodium chloride, Citric acid, HPMC, Sodium nitrite, and Benzalkonium Chloride. All components are used widely in the food industry and have a very strong safety profile. Do not use this product if you are sensitive to any of the ingredients 

Who can use: Adults and children older than 12 years of age. Children under the age of 12 years, or if you are pregnant or breastfeeding - consult a physician

Storage: Store at room temperature. Do not freeze.

SaNOtize NONS (stands for Nitric Oxide Nasal Spray) is branded as enovid™, VirX™, and Fabispray in certain countries.

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.


Recently viewed